SCHEMBL7652275

SCHEMBL7652275

CCCCS(=O)(=O)NNC(=O)c1ccc2nc(C)n(Cc3ccc(Cl)cc3Cl)c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.80
ALDH1A1 P00352 4/20 0.46
GAA P10253 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
THRB P10828 1/20 0.46
HPGD P15428 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652629 0.95 PPARG (0.77) PPARGALDH1A1GAAMEN1KMT2A
SCHEMBL1160177 0.91 PPARG (0.95) PPARGALDH1A1GAAMEN1KMT2A
Atx08-001 SCHEMBL682052 0.89 PPARG (1.00) PPARGALDH1A1GAAMEN1KMT2A
Atx08-001 SCHEMBL29368164 0.89 PPARG (1.00) PPARGALDH1A1GAAMEN1KMT2A
Atx08-001 SCHEMBL29691565 0.89 PPARG (1.00) PPARGALDH1A1GAAMEN1KMT2A
SCHEMBL27448720 0.87 PPARG (0.68) PPARGALDH1A1GAAMEN1KMT2A
SCHEMBL27451044 0.87 PPARG (0.68) PPARGALDH1A1GAAMEN1KMT2A
SCHEMBL27508300 0.86 PPARG (0.66) PPARGALDH1A1GAAMEN1KMT2A
SCHEMBL1178512 0.84 PPARG (0.82) PPARGALDH1A1GAAMEN1KMT2A
SCHEMBL7650777 0.84 PPARG (0.91) PPARGMEN1KMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP claimed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed